MedTrace Logo

User Performance and System Accuracy Evaluations Using Glucose Adjustment

NCT02374879 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-08-16

No results posted yet for this study

Summary

This is an open-label, non-randomised pilot study, to evaluate user performance and system accuracy in blood Glucose monitoring system with glucose adjustment. Twelve male and female volunteers aged 18-45, with a documented diagnosis of Type I diabetes for at least 12 will be enrolled in this study.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

Blood Glucose Monitoring Systems.

In vitro diagnostic medical device.

Sponsors & Collaborators

  • LifeScan

    lead INDUSTRY

Principal Investigators

  • David J Bell · BioKinetic Europe Ltd

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2015-02-01
Completion
2015-02-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02374879 on ClinicalTrials.gov